aluates Reports

$ 0.0

Automative

Global Kinase Inhibitors Market Insights, Forecast to 2030

Published Date: September 2024

Report Code: QYRE-Auto-13E9458

Global Kinase Inhibitors Market Insights and Forecast to 2028

BUY CHAPTERS

Global Kinase Inhibitors Market Insights, Forecast to 2030

Code: QYRE-Auto-13E9458

Report

September 2024

Pages:127

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Merck

Novartis

Pfizer Inc

Sanofi

GlaxoSmithKline PLC

Biogen Idec

Bayer HealthCare Pharmaceuticals

Johnson

Tolero Pharmaceutical

Astellas Pharma Inc

Eli Lilly and Co

Incyte Corp

Astrazeneca plc

Bristol–Myers Squibb

Boehringer Ingelheim International GmbH

F Hoffmann La Roche Ltd

Eisai Co Ltd

Rigel Pharmaceuticals

Mirati Therapeutics

BerGenBio

Kinase Inhibitors Market Size

The global Kinase Inhibitors market is projected to grow from US$ 57110 million in 2024 to US$ 73950 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.4% during the forecast period.

Kinase Inhibitors Market

Kinase inhibitors are considered as specific enzymes that help in preventing the process of cell division and the growth of cancerous cells. The kinase inhibitors are easy to use and are handy while treating cancer patients by blocking the signals that alert the cancer cells to grow. With the help of research and development activities in the cancer treatments, several innovations, and advanced therapeutics have been introduced. However, the results of these drugs and treatments are considered partial, palliative, and unpredictable at times. As a result, the key players in the market are emphasizing on research activities in order to introduce effective drugs and treatments and restrict the rising incidence of cancer across the globe.

The research study offers a comprehensive analysis of the global kinase inhibitors market, highlighting the primary factors that are likely to encourage the growth of the overall market in the near future. In addition, with the assistance of analytical tools, the research study throws light on the key drivers, promising opportunities, and limitations in the global kinase inhibitors market. The product portfolio, primary applications, key geographical segments, and the competitive scenario of the global market have been provided in the research study to offer the readers with a strong understanding of the market. Moreover, the market share, size, and the anticipated growth rate of the leading product and application segments have been provided in the research study.

Market Analysis and Insights: Global Kinase Inhibitors Market

The US & Canada market for Kinase Inhibitors is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Kinase Inhibitors is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Kinase Inhibitors is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Kinase Inhibitors include Merck, Novartis, Pfizer, Sanofi, GlaxoSmithKline, Biogen Idec, Bayer Healthcare Pharmaceuticals, Johnson and Tolero Pharmaceutical, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Kinase Inhibitors is widely used in various fields, such as Oncology, Inflammatory Diseases and Others,, etc. Oncology provides greatest supports to the Kinase Inhibitors industry development. In 2023, global % revenue of Kinase Inhibitors went into Oncology filed and the proportion will reach to % in 2030.

Report Covers:

This report presents an overview of global market for Kinase Inhibitors market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Kinase Inhibitors, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Kinase Inhibitors, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Kinase Inhibitors revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Kinase Inhibitors market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Kinase Inhibitors revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Kinase Inhibitors Market Report

Report Metric	Details
Report Name	Kinase Inhibitors Market
Accounted market size in 2024	US$ 57110 million
Forecasted market size in 2030	US$ 73950 million
CAGR	4.4
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	Non-receptor Tyrosine Kinase Inhibitors Receptor Tyrosine Kinase Inhibitors Multikinase Inhibitors Serine/Threonine Kinase Inhibitors Protein Kinase C Inhibitors RHO Kinase Inhibitors Others
Segment by Application	Oncology Inflammatory Diseases Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck, Novartis, Pfizer, Sanofi, GlaxoSmithKline, Biogen Idec, Bayer Healthcare Pharmaceuticals, Johnson, Tolero Pharmaceutical, Astellas Pharma Inc, Eli Lilly and Co, Incyte Corp, AstraZeneca, Bristol-Myers Squibb, Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd, Eisai Co., Ltd., BerGenBio, Rigel Pharmaceuticals, Mirati Therapeutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Kinase Inhibitors in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Kinase Inhibitors companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Kinase Inhibitors revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Kinase Inhibitors Market growing?

Ans: The Kinase Inhibitors Market witnessing a CAGR of 4.4 during the forecast period 2024-2030.

What is the Kinase Inhibitors Market size in 2030?

Ans: The Kinase Inhibitors Market size in 2030 will be US$ 73950 million.

Who are the main players in the Kinase Inhibitors Market report?

Ans: The main players in the Kinase Inhibitors Market are Merck, Novartis, Pfizer, Sanofi, GlaxoSmithKline, Biogen Idec, Bayer Healthcare Pharmaceuticals, Johnson, Tolero Pharmaceutical, Astellas Pharma Inc, Eli Lilly and Co, Incyte Corp, AstraZeneca, Bristol-Myers Squibb, Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd, Eisai Co., Ltd., BerGenBio, Rigel Pharmaceuticals, Mirati Therapeutics

What are the Application segmentation covered in the Kinase Inhibitors Market report?

Ans: The Applications covered in the Kinase Inhibitors Market report are Oncology, Inflammatory Diseases, Others

What are the Type segmentation covered in the Kinase Inhibitors Market report?

Ans: The Types covered in the Kinase Inhibitors Market report are Non-receptor Tyrosine Kinase Inhibitors, Receptor Tyrosine Kinase Inhibitors, Multikinase Inhibitors, Serine/Threonine Kinase Inhibitors, Protein Kinase C Inhibitors, RHO Kinase Inhibitors, Others

Recommended Reports

Kinase Inhibitors

Cancer Drug Markets

Cancer Subtypes & Targets

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Kinase Inhibitors Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Non-receptor Tyrosine Kinase Inhibitors

1.2.3 Receptor Tyrosine Kinase Inhibitors

1.2.4 Multikinase Inhibitors

1.2.5 Serine/Threonine Kinase Inhibitors

1.2.6 Protein Kinase C Inhibitors

1.2.7 RHO Kinase Inhibitors

1.2.8 Others

1.3 Market by Application

1.3.1 Global Kinase Inhibitors Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Oncology

1.3.3 Inflammatory Diseases

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Kinase Inhibitors Market Perspective (2019-2030)

2.2 Global Kinase Inhibitors Growth Trends by Region

2.2.1 Kinase Inhibitors Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Kinase Inhibitors Historic Market Size by Region (2019-2024)

2.2.3 Kinase Inhibitors Forecasted Market Size by Region (2025-2030)

2.3 Kinase Inhibitors Market Dynamics

2.3.1 Kinase Inhibitors Industry Trends

2.3.2 Kinase Inhibitors Market Drivers

2.3.3 Kinase Inhibitors Market Challenges

2.3.4 Kinase Inhibitors Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Kinase Inhibitors by Players

3.1.1 Global Kinase Inhibitors Revenue by Players (2019-2024)

3.1.2 Global Kinase Inhibitors Revenue Market Share by Players (2019-2024)

3.2 Global Kinase Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Kinase Inhibitors, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Kinase Inhibitors Market Concentration Ratio

3.4.1 Global Kinase Inhibitors Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Kinase Inhibitors Revenue in 2023

3.5 Global Key Players of Kinase Inhibitors Head office and Area Served

3.6 Global Key Players of Kinase Inhibitors, Product and Application

3.7 Global Key Players of Kinase Inhibitors, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Kinase Inhibitors Breakdown Data by Type

4.1 Global Kinase Inhibitors Historic Market Size by Type (2019-2024)

4.2 Global Kinase Inhibitors Forecasted Market Size by Type (2025-2030)

5 Kinase Inhibitors Breakdown Data by Application

5.1 Global Kinase Inhibitors Historic Market Size by Application (2019-2024)

5.2 Global Kinase Inhibitors Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Kinase Inhibitors Market Size (2019-2030)

6.2 North America Kinase Inhibitors Market Size by Type

6.2.1 North America Kinase Inhibitors Market Size by Type (2019-2024)

6.2.2 North America Kinase Inhibitors Market Size by Type (2025-2030)

6.2.3 North America Kinase Inhibitors Market Share by Type (2019-2030)

6.3 North America Kinase Inhibitors Market Size by Application

6.3.1 North America Kinase Inhibitors Market Size by Application (2019-2024)

6.3.2 North America Kinase Inhibitors Market Size by Application (2025-2030)

6.3.3 North America Kinase Inhibitors Market Share by Application (2019-2030)

6.4 North America Kinase Inhibitors Market Size by Country

6.4.1 North America Kinase Inhibitors Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Kinase Inhibitors Market Size by Country (2019-2024)

6.4.3 North America Kinase Inhibitors Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Kinase Inhibitors Market Size (2019-2030)

7.2 Europe Kinase Inhibitors Market Size by Type

7.2.1 Europe Kinase Inhibitors Market Size by Type (2019-2024)

7.2.2 Europe Kinase Inhibitors Market Size by Type (2025-2030)

7.2.3 Europe Kinase Inhibitors Market Share by Type (2019-2030)

7.3 Europe Kinase Inhibitors Market Size by Application

7.3.1 Europe Kinase Inhibitors Market Size by Application (2019-2024)

7.3.2 Europe Kinase Inhibitors Market Size by Application (2025-2030)

7.3.3 Europe Kinase Inhibitors Market Share by Application (2019-2030)

7.4 Europe Kinase Inhibitors Market Size by Country

7.4.1 Europe Kinase Inhibitors Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Kinase Inhibitors Market Size by Country (2019-2024)

7.4.3 Europe Kinase Inhibitors Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Kinase Inhibitors Market Size (2019-2030)

8.2 China Kinase Inhibitors Market Size by Type

8.2.1 China Kinase Inhibitors Market Size by Type (2019-2024)

8.2.2 China Kinase Inhibitors Market Size by Type (2025-2030)

8.2.3 China Kinase Inhibitors Market Share by Type (2019-2030)

8.3 China Kinase Inhibitors Market Size by Application

8.3.1 China Kinase Inhibitors Market Size by Application (2019-2024)

8.3.2 China Kinase Inhibitors Market Size by Application (2025-2030)

8.3.3 China Kinase Inhibitors Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Kinase Inhibitors Market Size (2019-2030)

9.2 Asia Kinase Inhibitors Market Size by Type

9.2.1 Asia Kinase Inhibitors Market Size by Type (2019-2024)

9.2.2 Asia Kinase Inhibitors Market Size by Type (2025-2030)

9.2.3 Asia Kinase Inhibitors Market Share by Type (2019-2030)

9.3 Asia Kinase Inhibitors Market Size by Application

9.3.1 Asia Kinase Inhibitors Market Size by Application (2019-2024)

9.3.2 Asia Kinase Inhibitors Market Size by Application (2025-2030)

9.3.3 Asia Kinase Inhibitors Market Share by Application (2019-2030)

9.4 Asia Kinase Inhibitors Market Size by Region

9.4.1 Asia Kinase Inhibitors Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Kinase Inhibitors Market Size by Region (2019-2024)

9.4.3 Asia Kinase Inhibitors Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Kinase Inhibitors Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Kinase Inhibitors Market Size by Type

10.2.1 Middle East, Africa, and Latin America Kinase Inhibitors Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Kinase Inhibitors Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Kinase Inhibitors Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Kinase Inhibitors Market Size by Application

10.3.1 Middle East, Africa, and Latin America Kinase Inhibitors Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Kinase Inhibitors Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Kinase Inhibitors Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Kinase Inhibitors Market Size by Country

10.4.1 Middle East, Africa, and Latin America Kinase Inhibitors Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Kinase Inhibitors Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Kinase Inhibitors Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Merck

11.1.1 Merck Company Details

11.1.2 Merck Business Overview

11.1.3 Merck Kinase Inhibitors Introduction

11.1.4 Merck Revenue in Kinase Inhibitors Business (2019-2024)

11.1.5 Merck Recent Developments

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Kinase Inhibitors Introduction

11.2.4 Novartis Revenue in Kinase Inhibitors Business (2019-2024)

11.2.5 Novartis Recent Developments

11.3 Pfizer

11.3.1 Pfizer Company Details

11.3.2 Pfizer Business Overview

11.3.3 Pfizer Kinase Inhibitors Introduction

11.3.4 Pfizer Revenue in Kinase Inhibitors Business (2019-2024)

11.3.5 Pfizer Recent Developments

11.4 Sanofi

11.4.1 Sanofi Company Details

11.4.2 Sanofi Business Overview

11.4.3 Sanofi Kinase Inhibitors Introduction

11.4.4 Sanofi Revenue in Kinase Inhibitors Business (2019-2024)

11.4.5 Sanofi Recent Developments

11.5 GlaxoSmithKline

11.5.1 GlaxoSmithKline Company Details

11.5.2 GlaxoSmithKline Business Overview

11.5.3 GlaxoSmithKline Kinase Inhibitors Introduction

11.5.4 GlaxoSmithKline Revenue in Kinase Inhibitors Business (2019-2024)

11.5.5 GlaxoSmithKline Recent Developments

11.6 Biogen Idec

11.6.1 Biogen Idec Company Details

11.6.2 Biogen Idec Business Overview

11.6.3 Biogen Idec Kinase Inhibitors Introduction

11.6.4 Biogen Idec Revenue in Kinase Inhibitors Business (2019-2024)

11.6.5 Biogen Idec Recent Developments

11.7 Bayer Healthcare Pharmaceuticals

11.7.1 Bayer Healthcare Pharmaceuticals Company Details

11.7.2 Bayer Healthcare Pharmaceuticals Business Overview

11.7.3 Bayer Healthcare Pharmaceuticals Kinase Inhibitors Introduction

11.7.4 Bayer Healthcare Pharmaceuticals Revenue in Kinase Inhibitors Business (2019-2024)

11.7.5 Bayer Healthcare Pharmaceuticals Recent Developments

11.8 Johnson

11.8.1 Johnson Company Details

11.8.2 Johnson Business Overview

11.8.3 Johnson Kinase Inhibitors Introduction

11.8.4 Johnson Revenue in Kinase Inhibitors Business (2019-2024)

11.8.5 Johnson Recent Developments

11.9 Tolero Pharmaceutical

11.9.1 Tolero Pharmaceutical Company Details

11.9.2 Tolero Pharmaceutical Business Overview

11.9.3 Tolero Pharmaceutical Kinase Inhibitors Introduction

11.9.4 Tolero Pharmaceutical Revenue in Kinase Inhibitors Business (2019-2024)

11.9.5 Tolero Pharmaceutical Recent Developments

11.10 Astellas Pharma Inc

11.10.1 Astellas Pharma Inc Company Details

11.10.2 Astellas Pharma Inc Business Overview

11.10.3 Astellas Pharma Inc Kinase Inhibitors Introduction

11.10.4 Astellas Pharma Inc Revenue in Kinase Inhibitors Business (2019-2024)

11.10.5 Astellas Pharma Inc Recent Developments

11.11 Eli Lilly and Co

11.11.1 Eli Lilly and Co Company Details

11.11.2 Eli Lilly and Co Business Overview

11.11.3 Eli Lilly and Co Kinase Inhibitors Introduction

11.11.4 Eli Lilly and Co Revenue in Kinase Inhibitors Business (2019-2024)

11.11.5 Eli Lilly and Co Recent Developments

11.12 Incyte Corp

11.12.1 Incyte Corp Company Details

11.12.2 Incyte Corp Business Overview

11.12.3 Incyte Corp Kinase Inhibitors Introduction

11.12.4 Incyte Corp Revenue in Kinase Inhibitors Business (2019-2024)

11.12.5 Incyte Corp Recent Developments

11.13 AstraZeneca

11.13.1 AstraZeneca Company Details

11.13.2 AstraZeneca Business Overview

11.13.3 AstraZeneca Kinase Inhibitors Introduction

11.13.4 AstraZeneca Revenue in Kinase Inhibitors Business (2019-2024)

11.13.5 AstraZeneca Recent Developments

11.14 Bristol-Myers Squibb

11.14.1 Bristol-Myers Squibb Company Details

11.14.2 Bristol-Myers Squibb Business Overview

11.14.3 Bristol-Myers Squibb Kinase Inhibitors Introduction

11.14.4 Bristol-Myers Squibb Revenue in Kinase Inhibitors Business (2019-2024)

11.14.5 Bristol-Myers Squibb Recent Developments

11.15 Boehringer Ingelheim International GmbH

11.15.1 Boehringer Ingelheim International GmbH Company Details

11.15.2 Boehringer Ingelheim International GmbH Business Overview

11.15.3 Boehringer Ingelheim International GmbH Kinase Inhibitors Introduction

11.15.4 Boehringer Ingelheim International GmbH Revenue in Kinase Inhibitors Business (2019-2024)

11.15.5 Boehringer Ingelheim International GmbH Recent Developments

11.16 F. Hoffmann-La Roche Ltd

11.16.1 F. Hoffmann-La Roche Ltd Company Details

11.16.2 F. Hoffmann-La Roche Ltd Business Overview

11.16.3 F. Hoffmann-La Roche Ltd Kinase Inhibitors Introduction

11.16.4 F. Hoffmann-La Roche Ltd Revenue in Kinase Inhibitors Business (2019-2024)

11.16.5 F. Hoffmann-La Roche Ltd Recent Developments

11.17 Eisai Co., Ltd.

11.17.1 Eisai Co., Ltd. Company Details

11.17.2 Eisai Co., Ltd. Business Overview

11.17.3 Eisai Co., Ltd. Kinase Inhibitors Introduction

11.17.4 Eisai Co., Ltd. Revenue in Kinase Inhibitors Business (2019-2024)

11.17.5 Eisai Co., Ltd. Recent Developments

11.18 BerGenBio

11.18.1 BerGenBio Company Details

11.18.2 BerGenBio Business Overview

11.18.3 BerGenBio Kinase Inhibitors Introduction

11.18.4 BerGenBio Revenue in Kinase Inhibitors Business (2019-2024)

11.18.5 BerGenBio Recent Developments

11.19 Rigel Pharmaceuticals

11.19.1 Rigel Pharmaceuticals Company Details

11.19.2 Rigel Pharmaceuticals Business Overview

11.19.3 Rigel Pharmaceuticals Kinase Inhibitors Introduction

11.19.4 Rigel Pharmaceuticals Revenue in Kinase Inhibitors Business (2019-2024)

11.19.5 Rigel Pharmaceuticals Recent Developments

11.20 Mirati Therapeutics

11.20.1 Mirati Therapeutics Company Details

11.20.2 Mirati Therapeutics Business Overview

11.20.3 Mirati Therapeutics Kinase Inhibitors Introduction

11.20.4 Mirati Therapeutics Revenue in Kinase Inhibitors Business (2019-2024)

11.20.5 Mirati Therapeutics Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Merck

Novartis

Pfizer Inc

Sanofi

GlaxoSmithKline PLC

Biogen Idec

Bayer HealthCare Pharmaceuticals

Johnson

Tolero Pharmaceutical

Astellas Pharma Inc

Eli Lilly and Co

Incyte Corp

Astrazeneca plc

Bristol–Myers Squibb

Boehringer Ingelheim International GmbH

F Hoffmann La Roche Ltd

Eisai Co Ltd

Rigel Pharmaceuticals

Mirati Therapeutics

BerGenBio

List of Tables

Table 1. Global Kinase Inhibitors Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Non-receptor Tyrosine Kinase Inhibitors

Table 3. Key Players of Receptor Tyrosine Kinase Inhibitors

Table 4. Key Players of Multikinase Inhibitors

Table 5. Key Players of Serine/Threonine Kinase Inhibitors

Table 6. Key Players of Protein Kinase C Inhibitors

Table 7. Key Players of RHO Kinase Inhibitors

Table 8. Key Players of Others

Table 9. Global Kinase Inhibitors Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 10. Global Kinase Inhibitors Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 11. Global Kinase Inhibitors Market Size by Region (2019-2024) & (US$ Million)

Table 12. Global Kinase Inhibitors Market Share by Region (2019-2024)

Table 13. Global Kinase Inhibitors Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 14. Global Kinase Inhibitors Market Share by Region (2025-2030)

Table 15. Kinase Inhibitors Market Trends

Table 16. Kinase Inhibitors Market Drivers

Table 17. Kinase Inhibitors Market Challenges

Table 18. Kinase Inhibitors Market Restraints

Table 19. Global Kinase Inhibitors Revenue by Players (2019-2024) & (US$ Million)

Table 20. Global Kinase Inhibitors Revenue Share by Players (2019-2024)

Table 21. Global Top Kinase Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kinase Inhibitors as of 2023)

Table 22. Global Kinase Inhibitors Industry Ranking 2022 VS 2023 VS 2024

Table 23. Global 5 Largest Players Market Share by Kinase Inhibitors Revenue (CR5 and HHI) & (2019-2024)

Table 24. Global Key Players of Kinase Inhibitors, Headquarters and Area Served

Table 25. Global Key Players of Kinase Inhibitors, Product and Application

Table 26. Global Key Players of Kinase Inhibitors, Product and Application

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Kinase Inhibitors Market Size by Type (2019-2024) & (US$ Million)

Table 29. Global Kinase Inhibitors Revenue Market Share by Type (2019-2024)

Table 30. Global Kinase Inhibitors Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 31. Global Kinase Inhibitors Revenue Market Share by Type (2025-2030)

Table 32. Global Kinase Inhibitors Market Size by Application (2019-2024) & (US$ Million)

Table 33. Global Kinase Inhibitors Revenue Share by Application (2019-2024)

Table 34. Global Kinase Inhibitors Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 35. Global Kinase Inhibitors Revenue Share by Application (2025-2030)

Table 36. North America Kinase Inhibitors Market Size by Type (2019-2024) & (US$ Million)

Table 37. North America Kinase Inhibitors Market Size by Type (2025-2030) & (US$ Million)

Table 38. North America Kinase Inhibitors Market Size by Application (2019-2024) & (US$ Million)

Table 39. North America Kinase Inhibitors Market Size by Application (2025-2030) & (US$ Million)

Table 40. North America Kinase Inhibitors Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. North America Kinase Inhibitors Market Size by Country (2019-2024) & (US$ Million)

Table 42. North America Kinase Inhibitors Market Size by Country (2025-2030) & (US$ Million)

Table 43. Europe Kinase Inhibitors Market Size by Type (2019-2024) & (US$ Million)

Table 44. Europe Kinase Inhibitors Market Size by Type (2025-2030) & (US$ Million)

Table 45. Europe Kinase Inhibitors Market Size by Application (2019-2024) & (US$ Million)

Table 46. Europe Kinase Inhibitors Market Size by Application (2025-2030) & (US$ Million)

Table 47. Europe Kinase Inhibitors Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 48. Europe Kinase Inhibitors Market Size by Country (2019-2024) & (US$ Million)

Table 49. Europe Kinase Inhibitors Market Size by Country (2025-2030) & (US$ Million)

Table 50. China Kinase Inhibitors Market Size by Type (2019-2024) & (US$ Million)

Table 51. China Kinase Inhibitors Market Size by Type (2025-2030) & (US$ Million)

Table 52. China Kinase Inhibitors Market Size by Application (2019-2024) & (US$ Million)

Table 53. China Kinase Inhibitors Market Size by Application (2025-2030) & (US$ Million)

Table 54. Asia Kinase Inhibitors Market Size by Type (2019-2024) & (US$ Million)

Table 55. Asia Kinase Inhibitors Market Size by Type (2025-2030) & (US$ Million)

Table 56. Asia Kinase Inhibitors Market Size by Application (2019-2024) & (US$ Million)

Table 57. Asia Kinase Inhibitors Market Size by Application (2025-2030) & (US$ Million)

Table 58. Asia Kinase Inhibitors Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 59. Asia Kinase Inhibitors Market Size by Region (2019-2024) & (US$ Million)

Table 60. Asia Kinase Inhibitors Market Size by Region (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Kinase Inhibitors Market Size by Type (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Kinase Inhibitors Market Size by Type (2025-2030) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Kinase Inhibitors Market Size by Application (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Kinase Inhibitors Market Size by Application (2025-2030) & (US$ Million)

Table 65. Middle East, Africa, and Latin America Kinase Inhibitors Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 66. Middle East, Africa, and Latin America Kinase Inhibitors Market Size by Country (2019-2024) & (US$ Million)

Table 67. Middle East, Africa, and Latin America Kinase Inhibitors Market Size by Country (2025-2030) & (US$ Million)

Table 68. Merck Company Details

Table 69. Merck Business Overview

Table 70. Merck Kinase Inhibitors Product

Table 71. Merck Revenue in Kinase Inhibitors Business (2019-2024) & (US$ Million)

Table 72. Merck Recent Developments

Table 73. Novartis Company Details

Table 74. Novartis Business Overview

Table 75. Novartis Kinase Inhibitors Product

Table 76. Novartis Revenue in Kinase Inhibitors Business (2019-2024) & (US$ Million)

Table 77. Novartis Recent Developments

Table 78. Pfizer Company Details

Table 79. Pfizer Business Overview

Table 80. Pfizer Kinase Inhibitors Product

Table 81. Pfizer Revenue in Kinase Inhibitors Business (2019-2024) & (US$ Million)

Table 82. Pfizer Recent Developments

Table 83. Sanofi Company Details

Table 84. Sanofi Business Overview

Table 85. Sanofi Kinase Inhibitors Product

Table 86. Sanofi Revenue in Kinase Inhibitors Business (2019-2024) & (US$ Million)

Table 87. Sanofi Recent Developments

Table 88. GlaxoSmithKline Company Details

Table 89. GlaxoSmithKline Business Overview

Table 90. GlaxoSmithKline Kinase Inhibitors Product

Table 91. GlaxoSmithKline Revenue in Kinase Inhibitors Business (2019-2024) & (US$ Million)

Table 92. GlaxoSmithKline Recent Developments

Table 93. Biogen Idec Company Details

Table 94. Biogen Idec Business Overview

Table 95. Biogen Idec Kinase Inhibitors Product

Table 96. Biogen Idec Revenue in Kinase Inhibitors Business (2019-2024) & (US$ Million)

Table 97. Biogen Idec Recent Developments

Table 98. Bayer Healthcare Pharmaceuticals Company Details

Table 99. Bayer Healthcare Pharmaceuticals Business Overview

Table 100. Bayer Healthcare Pharmaceuticals Kinase Inhibitors Product

Table 101. Bayer Healthcare Pharmaceuticals Revenue in Kinase Inhibitors Business (2019-2024) & (US$ Million)

Table 102. Bayer Healthcare Pharmaceuticals Recent Developments

Table 103. Johnson Company Details

Table 104. Johnson Business Overview

Table 105. Johnson Kinase Inhibitors Product

Table 106. Johnson Revenue in Kinase Inhibitors Business (2019-2024) & (US$ Million)

Table 107. Johnson Recent Developments

Table 108. Tolero Pharmaceutical Company Details

Table 109. Tolero Pharmaceutical Business Overview

Table 110. Tolero Pharmaceutical Kinase Inhibitors Product

Table 111. Tolero Pharmaceutical Revenue in Kinase Inhibitors Business (2019-2024) & (US$ Million)

Table 112. Tolero Pharmaceutical Recent Developments

Table 113. Astellas Pharma Inc Company Details

Table 114. Astellas Pharma Inc Business Overview

Table 115. Astellas Pharma Inc Kinase Inhibitors Product

Table 116. Astellas Pharma Inc Revenue in Kinase Inhibitors Business (2019-2024) & (US$ Million)

Table 117. Astellas Pharma Inc Recent Developments

Table 118. Eli Lilly and Co Company Details

Table 119. Eli Lilly and Co Business Overview

Table 120. Eli Lilly and Co Kinase Inhibitors Product

Table 121. Eli Lilly and Co Revenue in Kinase Inhibitors Business (2019-2024) & (US$ Million)

Table 122. Eli Lilly and Co Recent Developments

Table 123. Incyte Corp Company Details

Table 124. Incyte Corp Business Overview

Table 125. Incyte Corp Kinase Inhibitors Product

Table 126. Incyte Corp Revenue in Kinase Inhibitors Business (2019-2024) & (US$ Million)

Table 127. Incyte Corp Recent Developments

Table 128. AstraZeneca Company Details

Table 129. AstraZeneca Business Overview

Table 130. AstraZeneca Kinase Inhibitors Product

Table 131. AstraZeneca Revenue in Kinase Inhibitors Business (2019-2024) & (US$ Million)

Table 132. AstraZeneca Recent Developments

Table 133. Bristol-Myers Squibb Company Details

Table 134. Bristol-Myers Squibb Business Overview

Table 135. Bristol-Myers Squibb Kinase Inhibitors Product

Table 136. Bristol-Myers Squibb Revenue in Kinase Inhibitors Business (2019-2024) & (US$ Million)

Table 137. Bristol-Myers Squibb Recent Developments

Table 138. Boehringer Ingelheim International GmbH Company Details

Table 139. Boehringer Ingelheim International GmbH Business Overview

Table 140. Boehringer Ingelheim International GmbH Kinase Inhibitors Product

Table 141. Boehringer Ingelheim International GmbH Revenue in Kinase Inhibitors Business (2019-2024) & (US$ Million)

Table 142. Boehringer Ingelheim International GmbH Recent Developments

Table 143. F. Hoffmann-La Roche Ltd Company Details

Table 144. F. Hoffmann-La Roche Ltd Business Overview

Table 145. F. Hoffmann-La Roche Ltd Kinase Inhibitors Product

Table 146. F. Hoffmann-La Roche Ltd Revenue in Kinase Inhibitors Business (2019-2024) & (US$ Million)

Table 147. F. Hoffmann-La Roche Ltd Recent Developments

Table 148. Eisai Co., Ltd. Company Details

Table 149. Eisai Co., Ltd. Business Overview

Table 150. Eisai Co., Ltd. Kinase Inhibitors Product

Table 151. Eisai Co., Ltd. Revenue in Kinase Inhibitors Business (2019-2024) & (US$ Million)

Table 152. Eisai Co., Ltd. Recent Developments

Table 153. BerGenBio Company Details

Table 154. BerGenBio Business Overview

Table 155. BerGenBio Kinase Inhibitors Product

Table 156. BerGenBio Revenue in Kinase Inhibitors Business (2019-2024) & (US$ Million)

Table 157. BerGenBio Recent Developments

Table 158. Rigel Pharmaceuticals Company Details

Table 159. Rigel Pharmaceuticals Business Overview

Table 160. Rigel Pharmaceuticals Kinase Inhibitors Product

Table 161. Rigel Pharmaceuticals Revenue in Kinase Inhibitors Business (2019-2024) & (US$ Million)

Table 162. Rigel Pharmaceuticals Recent Developments

Table 163. Mirati Therapeutics Company Details

Table 164. Mirati Therapeutics Business Overview

Table 165. Mirati Therapeutics Kinase Inhibitors Product

Table 166. Mirati Therapeutics Revenue in Kinase Inhibitors Business (2019-2024) & (US$ Million)

Table 167. Mirati Therapeutics Recent Developments

Table 168. Research Programs/Design for This Report

Table 169. Key Data Information from Secondary Sources

Table 170. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Kinase Inhibitors Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Kinase Inhibitors Market Share by Type: 2023 VS 2030

Figure 3. Non-receptor Tyrosine Kinase Inhibitors Features

Figure 4. Receptor Tyrosine Kinase Inhibitors Features

Figure 5. Multikinase Inhibitors Features

Figure 6. Serine/Threonine Kinase Inhibitors Features

Figure 7. Protein Kinase C Inhibitors Features

Figure 8. RHO Kinase Inhibitors Features

Figure 9. Others Features

Figure 10. Global Kinase Inhibitors Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 11. Global Kinase Inhibitors Market Share by Application: 2023 VS 2030

Figure 12. Oncology Case Studies

Figure 13. Inflammatory Diseases Case Studies

Figure 14. Others Case Studies

Figure 15. Kinase Inhibitors Report Years Considered

Figure 16. Global Kinase Inhibitors Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 17. Global Kinase Inhibitors Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 18. Global Kinase Inhibitors Market Share by Region: 2023 VS 2030

Figure 19. Global Kinase Inhibitors Market Share by Players in 2023

Figure 20. Global Top Kinase Inhibitors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kinase Inhibitors as of 2023)

Figure 21. The Top 10 and 5 Players Market Share by Kinase Inhibitors Revenue in 2023

Figure 22. North America Kinase Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. North America Kinase Inhibitors Market Share by Type (2019-2030)

Figure 24. North America Kinase Inhibitors Market Share by Application (2019-2030)

Figure 25. North America Kinase Inhibitors Market Share by Country (2019-2030)

Figure 26. United States Kinase Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Canada Kinase Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Europe Kinase Inhibitors Market Size YoY (2019-2030) & (US$ Million)

Figure 29. Europe Kinase Inhibitors Market Share by Type (2019-2030)

Figure 30. Europe Kinase Inhibitors Market Share by Application (2019-2030)

Figure 31. Europe Kinase Inhibitors Market Share by Country (2019-2030)

Figure 32. Germany Kinase Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. France Kinase Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. U.K. Kinase Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Italy Kinase Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Russia Kinase Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Nordic Countries Kinase Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. China Kinase Inhibitors Market Size YoY (2019-2030) & (US$ Million)

Figure 39. China Kinase Inhibitors Market Share by Type (2019-2030)

Figure 40. China Kinase Inhibitors Market Share by Application (2019-2030)

Figure 41. Asia Kinase Inhibitors Market Size YoY (2019-2030) & (US$ Million)

Figure 42. Asia Kinase Inhibitors Market Share by Type (2019-2030)

Figure 43. Asia Kinase Inhibitors Market Share by Application (2019-2030)

Figure 44. Asia Kinase Inhibitors Market Share by Region (2019-2030)

Figure 45. Japan Kinase Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. South Korea Kinase Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. China Taiwan Kinase Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Southeast Asia Kinase Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. India Kinase Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Australia Kinase Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Middle East, Africa, and Latin America Kinase Inhibitors Market Size YoY (2019-2030) & (US$ Million)

Figure 52. Middle East, Africa, and Latin America Kinase Inhibitors Market Share by Type (2019-2030)

Figure 53. Middle East, Africa, and Latin America Kinase Inhibitors Market Share by Application (2019-2030)

Figure 54. Middle East, Africa, and Latin America Kinase Inhibitors Market Share by Country (2019-2030)

Figure 55. Brazil Kinase Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Mexico Kinase Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Turkey Kinase Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Saudi Arabia Kinase Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. Israel Kinase Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 60. GCC Countries Kinase Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 61. Merck Revenue Growth Rate in Kinase Inhibitors Business (2019-2024)

Figure 62. Novartis Revenue Growth Rate in Kinase Inhibitors Business (2019-2024)

Figure 63. Pfizer Revenue Growth Rate in Kinase Inhibitors Business (2019-2024)

Figure 64. Sanofi Revenue Growth Rate in Kinase Inhibitors Business (2019-2024)

Figure 65. GlaxoSmithKline Revenue Growth Rate in Kinase Inhibitors Business (2019-2024)

Figure 66. Biogen Idec Revenue Growth Rate in Kinase Inhibitors Business (2019-2024)

Figure 67. Bayer Healthcare Pharmaceuticals Revenue Growth Rate in Kinase Inhibitors Business (2019-2024)

Figure 68. Johnson Revenue Growth Rate in Kinase Inhibitors Business (2019-2024)

Figure 69. Tolero Pharmaceutical Revenue Growth Rate in Kinase Inhibitors Business (2019-2024)

Figure 70. Astellas Pharma Inc Revenue Growth Rate in Kinase Inhibitors Business (2019-2024)

Figure 71. Eli Lilly and Co Revenue Growth Rate in Kinase Inhibitors Business (2019-2024)

Figure 72. Incyte Corp Revenue Growth Rate in Kinase Inhibitors Business (2019-2024)

Figure 73. AstraZeneca Revenue Growth Rate in Kinase Inhibitors Business (2019-2024)

Figure 74. Bristol-Myers Squibb Revenue Growth Rate in Kinase Inhibitors Business (2019-2024)

Figure 75. Boehringer Ingelheim International GmbH Revenue Growth Rate in Kinase Inhibitors Business (2019-2024)

Figure 76. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Kinase Inhibitors Business (2019-2024)

Figure 77. Eisai Co., Ltd. Revenue Growth Rate in Kinase Inhibitors Business (2019-2024)

Figure 78. BerGenBio Revenue Growth Rate in Kinase Inhibitors Business (2019-2024)

Figure 79. Rigel Pharmaceuticals Revenue Growth Rate in Kinase Inhibitors Business (2019-2024)

Figure 80. Mirati Therapeutics Revenue Growth Rate in Kinase Inhibitors Business (2019-2024)

Figure 81. Bottom-up and Top-down Approaches for This Report

Figure 82. Data Triangulation

Figure 83. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Creatine Kinase Test Market Insights Forecast to 2030

Small Molecule Inhibitors for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Drug Delivery in Cancer Market Insights Forecast to 2030

Global Enzyme Poly ADP Ribose Polymerase PARP Inhibitor Market Insights Forecast to 2030

Global Anti PD 1 MAb Market Insights Forecast to 2030

Global Drug Discovery Assays Market Insights Forecast to 2030

Global Cancer Immunotherapy Drug Discovery Outsourcing Market Insights Forecast to 2030

Global Kinase Inhibitors For Cancer Treatment Market Research Report 2024

Global CPK MB Test Market Insights Forecast to 2030

Global CK MB Test Market Insights Forecast to 2030

Global Metastatic Colorectal Cancer Drug Market Insights Forecast to 2030

Global Cancer Angiogenesis Inhibitors Market Research Report 2024

Global Tyrosine Kinase Inhibitor Market Research Report 2024

Global Non Tyrosine Kinase Inhibitors Market Research Report 2025

Global Mitogen Activated Protein Kinase MAPK Inhibitors Therapeutics Market Research Report 2024

Global Radotinib Market Research Report 2024

Global Primary Cell Culture Market Insights Forecast to 2030

Cell Cycle Inhibitors Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Targeted Drug MEK Inhibitors for NSCLC Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions